COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04978051


Column Value
Trial registration number NCT04978051
Full text link
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

First author
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

Not reported

Contact
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

Not reported

Registration date
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

2021-07-27

Recruitment status
Last imported at : Aug. 4, 2022, 4:30 p.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

Open label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

inclusion criteria: adult patients (18 years or older), both sexes sars-cov-2 infection confirmed by pcr less than 4 days before randomization hospitalized with a diagnosis of sars-cov-2 pneumonia radiographic evidence of pulmonary infiltrates grade 4 or 5 on the ordinal scale for the evaluation of the patient's clinical condition po2/fio2 <380 men and women of childbearing age who have heterosexual relations must be agreement to use the safe method(s) of contraception obtaining the informed consent of the patient or the legal representative.

Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

imminent death (life expectancy less than 72h) known hypersensitivity or known adverse reactions to the study drug, or its metabolites or excipients of the formulation invasive mechanical ventilation participation in any other clinical trial alt or ast > 5 x uln creatinine clearance <50 ml/min using the cockcroft-gault formula for participants '18 years old [cockcroft 1976] patients with recent acute coronary syndrome (<1 month) patients with a history of stroke positive pregnancy test pregnant or lactating woman

Number of arms
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

2

Funding
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

Sebastian Videla

Inclusion age min
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

100

Countries
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

Spain

Type of patients
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

Moderate/severe disease at enrollment

Severity scale
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : Aug. 4, 2022, 4:30 p.m.
Source : ClinicalTrials.gov

73

primary outcome
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

Efficacy of experimental treatment;Safety of experimental treatment

Notes
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

None

Phase
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

Phase 2

Arms
Last imported at : July 28, 2021, noon
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 621, "treatment_name": "Icatibant", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]